Mice tumor free and protected from metastases after treatment
The shells of a common plant virus, inhaled into a lung tumor or injected into ovarian, colon or breast tumors, not only triggered the immune system in mice to wipe out the tumors, but provided systemic protection against metastases, researchers from Case Western Reserve University and Dartmouth University report.
The scientists tested a 100-year-old idea called in-situ vaccination. The idea is to put something inside a tumor and disrupt the environment that suppresses the immune system, thus allowing the natural defense system to attack the malignancy.
That something–the hard coating of cowpea mosaic virus–caused no detectible side effects, which are a common problem with traditional therapies and some immunotherapies.
The team’s research is published in the journal Nature Nanotechnology.
“The cowpea virus-based nanoparticles act like a switch that turns on the immune system to recognize and fight against the tumor – as well as to remember it,” said Nicole Steinmetz, an assistant professor of biomedical engineering at Case Western Reserve, appointed by the Case Western Reserve School of Medicine.
“The particles are shockingly potent,” said Steven Fiering, professor of microbiology and immunology at Dartmouth’s Geisel School of Medicine. “They’re easy to make and don’t need to carry antigens, drugs or other immunostimmulatory agents on their surface or inside.”
The professors studied the nanoparticles with Dartmouth’s Pat Lizotte, a molecular and cellular biology PhD student; Mee Rie Sheen, a postdoctoral fellow; and Pakdee Rojanasopondist, an undergraduate student; and Case Western Reserve’s Amy Wen, a biomedical engineering PhD student.
Taking another shot
The immune system’s ability to detect and destroy abnormal cells is thought to prevent many cancers, according to the National Cancer Institute. But when tumors start to develop, they can shut down the system, allowing tumors to grow and spread.
To restart immune defenses, the scientists used the tumor itself as if it were the antigen in a vaccine–that is, the target for antibodies produced by the immune system.
The cowpea virus shell, with its infectious components removed, acts as the adjuvant–a substance that triggers and may enhance or prolong antigen-specific immune responses.
The process and results
The researchers first switched on the immune system in mice to attack B16F10 lung melanoma or skin melanoma, leaving the mice tumor-free. When the treated mice were later injected with B16F10 skin melanoma (to re-challenge the cured mice), four out of five mice were soon cancer free and one had a slow-growing tumor.
The nanoparticles proved effective against ovarian, breast and colon tumor models. Most of the tumors deteriorated from the center and collapsed. The systemic response prevented or attacked metastatic disease, which is the deadliest form of cancer.
“You get benefits against disease you don’t even know is there yet,” Fiering said.
“Because everything we do is local, the side effects are limited,” despite the strength and extent of the immune response, Fiering said. No toxicity was found.
Harsh side effects, such as fatigue, pain, flu-like symptoms and more are common with chemo and radiation therapies and with some immunostimulation drugs.
The researchers are now trying to understand how the virus shell stimulates the immune system.
“It’s not cytotoxic, there’s no RNA involved or lipopolysaccharides that may be used as adjuvants, and it’s not simply an irritant,” Steinmetz said. “We see a specific immune response.”
The Latest on: Immune response against cancer
via Google News
The Latest on:Iimmune response against cancer
- Immunotherapy using 'young cells' offers promising option against canceron March 23, 2020 at 6:21 am
Immunotherapy that involves treating cancer with the body's own immune cells, or those of a matched donor ... NK cells of adult origin also release different chemicals that trigger harmful ...
- The bacteria-trapping protein that may provide a new target for tracking and treating breast canceron March 20, 2020 at 8:19 am
Scientists at the Pennsylvania State University and Henan University in China have found a new protein marker that they say could potentially predict the progression of breast cancer or be targeted by ...
- Glioblastoma infiltration of both tumor- and virus-antigen specific cytotoxic T cells correlates with experimental virotherapy responseson March 20, 2020 at 3:11 am
The mode of action for oncolytic viruses (OVs) in cancer treatment is thought to depend on a direct initial cytotoxic effect against infected tumor cells and subsequent activation of immune cell ...
- Study paves way for identifying ovarian cancer patients who will not benefit from combination therapyon March 19, 2020 at 7:57 am
... PARP prevents it from carrying out this repair in cancer cells, which then die as a result. Immune checkpoints are molecules found on the surface of certain immune cells that become activated or ...
- Nelipepimut-S Combination Demonstrates 11-Fold Increase in Immune Response in Breast DCISon March 19, 2020 at 7:50 am
controls, even with a single NPS inoculation, indicate in vivo immunogenicity of this cancer vaccine in DCIS. These data ... “While additional analyses of certain histologic and molecular markers of ...
- New research shows which ovarian cancer patients won't benefit from immune-PARP comboon March 19, 2020 at 3:00 am
Smith Center for Women's Cancers. While checkpoint inhibitors—which strip tumors of certain protections against an attack by the immune system—work exceptionally well in many types of cancer, ovarian ...
- Boosting immune responses against early breast canceron March 18, 2020 at 11:13 am
Pembrolizumab combined with neoadjuvant chemotherapy improves therapeutic responses in patients with early triple-negative breast cancer. Immune checkpoint inhibitors such as antibodies against ...
- 5 ways to boost your immune system against coronaviruson March 18, 2020 at 9:00 am
The coronavirus (Covid-19) presents many uncertainties, and none of us can completely eliminate our risk of getting it, but one thing we can do is take the necessary precautions. If we do catch the ...
- How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatmenton March 11, 2020 at 6:44 am
... other stimulatory receptors like CD28 to limit the immune responses against weak self- and tumor antigens. PD-1, on the other hand, plays an important role in inhibitor immune signaling, in which ...
- Why vitamin C won't 'boost' your immune system against the coronaviruson March 10, 2020 at 4:00 am
Pauling claimed that taking large doses of vitamin C could not only prevent the common cold, but also help thwart more severe illnesses like cancer and heart ... and defends these cells against free ...
via Bing News